CClinicalTrials.gg
Sign In
Status unknownNCT04206111Updated Jun 16, 2020

Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

An observational study in Gastric Ultrasound, sponsored by University of Liege. Status unknown at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-06-16.

Sponsored by University of Liege · Observational

The sponsor has not verified this record recently (last verified Jun 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

Check in gastric ultrasound for lack of stomach insufflation during preoxygenation with high-flow nasal cannulas

02

Conditions studied

  • Gastric Ultrasound
03

In context

Lead sponsor

University of Liege is the lead sponsor of 242 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adults

Inclusion criteria

  • Adults Volunteers

Exclusion criteria

Exclusion Criteria:

  • History of gastric surgery
  • Facial or oropharyngeal abnormality
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Preoxygenation

    Procedure: Preoxygenation

Interventions

  • ProcedurePreoxygenation

    preoxygenation with high flow nasal cannula at 40l/min for 5min

06

What researchers measure

Primary outcomes

  1. no gastric insufflation

    Number of Participants with no gastric insufflation

    Time frame: From date of randomization until the date of first documented progression, whichever came first, assessed up to 6 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04206111
Lead sponsor
University of Liege
Responsible party
Benjamin Javillier (Principal Investigator, University of Liege) — Principal investigator
First posted
Dec 20, 2019
Start date
Jun 1, 2020
Primary completion
Sep 1, 2020 (estimated)
Completion
Oct 1, 2020 (estimated)
Last update
Jun 16, 2020

Study contacts

Benjamin Javillier, MD
Contact
benjamin.javillier@chuliege.be
003243667180

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University of Liege

Start the discussion